跳至主要内容
临床试验/CTRI/2024/08/072427
CTRI/2024/08/072427尚未招募4 期

Effectiveness and Safety of Oral Methotrexate versus Oral tofacitinib in the Treatment of Chronic Plaque Psoriasis-A Randomized control trial - NI

Rishana0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Chronic plaque psoriasis with PASI more than 10.
  • Patient with nail psoriasis.
  • Patient with Psoriatic arthritis.

排除标准

  • Pregnancy and lactation.
  • Females and males who were planning to have a child and not willing for using contraception.
  • Systemic therapy taken for psoriasis in the past 4 weeks before enrolling into the study.
  • Topical therapy taken for psoriasis in past 2 weeks before enrolling into the study.
  • Acute or chronic liver disease or renal disease/ uncontrolled hypertension/ uncontrolled Diabetes mellitus.
  • known allergy to any of the study drugs.
  • Active infection such as Tuberculosis, HIV, Hepatitis B and C.
  • History of disseminated herpes zoster or herpes simplex or recurrent localized dermatomal herpes zoster.
  • Patient on any other immunosuppressants.

研究者

发起方
Rishana

相似试验